- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
InterMune Inc+ Add to Watchlist
ITMN:US32.0900 USD 1.1700 3.52%
As of 20:10:00 ET on 03/14/2014.
Company Profile for InterMune Inc (ITMN)
InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.
Key Executives for InterMune Inc (ITMN)
|Daniel G Welch "Dan"Chairman/President/CEO||John HodgmanExec VP/CFO|
|Sean P NolanExec VP/Chief Business Officer||Giacomo Di NepiExec VP/Managing Dir:Europe|
|Andrew K W PowellExec VP/Secretary/General Counsel||Jonathan A LeffExec VP:Research & Development|
|Paul D ArataExec VP:HR & Administration|